FDA Inspection 1221647 — Sunil Maheshwari, MBBS
The FDA completed an inspection of Sunil Maheshwari, MBBS on Oct 23, 2023 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 23, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ahmedabad (India)
Additional Details
Clinical BA/BE